Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;225(1):43-53.
doi: 10.1002/path.2915. Epub 2011 Jun 1.

MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin

Affiliations

MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin

Manuela Ferracin et al. J Pathol. 2011 Sep.

Abstract

Cancer of unknown primary (CUP) represents a common and important clinical problem. There is evidence that most CUPs are metastases of carcinomas whose primary site cannot be recognized. Driven by the hypothesis that the knowledge of primary cancer could improve patient's prognosis, we investigated microRNA expression profiling as a tool for identifying the tissue of origin of metastases. We assessed microRNA expression from 101 formalin-fixed, paraffin-embedded (FFPE) samples from primary cancers and metastasis samples by using a microarray platform. Forty samples representing ten different cancer types were used for defining a cancer-type-specific microRNA signature, which was used for predicting primary sites of metastatic cancers. A 47-miRNA signature was identified and used to estimate tissue-of-origin probabilities for each sample. Overall, accuracy reached 100% for primary cancers and 78% for metastases in our cohort of samples. When the signature was applied to an independent published dataset of 170 samples, accuracy remained high: correct prediction was found within the first two options in 86% of the metastasis cases (first prediction was correct in 68% of cases). This signature was also applied to predict 16 CUPs. In this group, first predictions exhibited probabilities higher than 90% in most of the cases. These results establish that FFPE samples can be used to reveal the tissue of origin of metastatic cancers by using microRNA expression profiling and suggest that the approach, if applied, could provide strong indications for CUPs, whose correct diagnosis is presently undefined.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest were declared.

Figures

Figure 1
Figure 1
Classification of 40 carcinomas using the 47-miRNA signature. Cluster analysis of 40 primary carcinomas in accordance to the expression of the 47-miRNA classifier. Samples are grouped according to their tissue of origin. The colours of the genes represented on the heat map correspond to the expression values normalized on miRNA mean expression across all samples: green indicates down-regulated; red indicates up-regulated in the sample.
Figure 2
Figure 2
Average expression of 47 miRNAs in primary and metastatic tumours. Heat-map representation of the average expression of 47 miRNAs in metastatic and primary carcinomas from ten different tissues. Metastases and primaries from the same origin exhibit highly similar miRNA expression and are grouped together. The colours of the genes represented on the heat map correspond to the expression values normalized on miRNA mean expression across all samples: green indicates down-regulated; red indicates up-regulated in the tissue.

References

    1. Briasoulis E, Tolis C, Bergh J, et al. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP) Ann Oncol. 2005;16(Suppl 1):i75–i76. - PubMed
    1. Oien KA. Pathologic evaluation of unknown primary cancer. Sem Oncol. 2009;36:8–37. - PubMed
    1. Pavlidis N, Fizazi K. Cancer of unknown primary (CUP) Crit Rev Oncol Hematol. 2005;54:243–250. - PubMed
    1. Freudenberg LS, Rosenbaum-Krumme SJ, Bockisch A, et al. Cancer of unknown primary. Recent Results Cancer Res. 2008;170:193–202. - PubMed
    1. Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer. 2004;100:1776–1785. - PubMed

Publication types